News

“In November 2022, a study revealed that blood pressure drugs that stimulate type 2 and 4 angiotensin II receptors in the brain were associated with lower rates of dementia among new users of ...
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.
In a nutshell People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared to those on other diabetes medications The protective effects were ...
Blockbuster weight loss jabs relied on by millions of slimmers could slash the risk of developing dementia, two major studies have suggested. Semaglutide — the powerful ingredient behind Wegovy ...
There is currently no known cure for dementia, as Xu notes. But up to half of all dementia cases might be preventable, and scientists have identified over a dozen modifiable risk factors that ...
New study suggests that Novo Nordisk’s Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group’s cyberattack woes aren’t over yet.
Ozempic May Lower Your Dementia Risk, New Study Suggests. A Neurologist Explains The Potential Link. It all has to do with inflammation. By Korin Miller Published: Jan 21, 2025 12:01 PM EST.
A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia.
A study finds a drug known for weight loss may also help to reduce dementia. The study looked at semaglutide, the scientific name for Novo Nordisk's (NVO) (DK:NOVO.B) Ozempic, with the intent of ...
Novo Nordisk rose Friday after the release of an Oxford study that showed the Danish company’s diabetes drug Ozempic was linked to lower rates of dementia and a range of mental problems.